Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Bartlett who wrote (3164)	1/19/2000 8:09:00 PM
From: DaveAu	of 14101

<<That could (POTENTIALLY) make it the drug of choice for just about every AIDS person going ALONG with there other meds>> Mark, I agree that WF10 could be big since it will not compete with the the existing drug cocktails and in fact may help them work better. I'm not sure however if it might be used only in later stage patients. In one of the phase 2 studies, I found this statement "... and among the patients with >300 CD4 cells there was no significant change in immune phenotypes". In the phase 3 trial, they're looking for patients with levels below 50 I believe. I'm not sure what the level would be for the average patient. Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next